Changes in Sexual Function After Minimally Invasive Hysterectomy in Reproductive-Aged Women: A Systematic Review and...

One primary concern among patients undergoing minimally invasive hysterectomy (MIH) is postsurgical sexual function. Conflicting evidence exists due to variability in the sexual function measures, the menopause status of patients, and the inclusion of data from laparotomies. The purpose of this systematic review and meta-analysis was to evaluate the effects of MIH on sexual function in premenopausal women while accounting for these confounders.

Data search was conducted in PubMed, Google Scholar, Cochrane Central Register of Controlled Trials, Scopus, Science Direct, ProQuest, and EBSCO from inception to December 31, 2024.

The initial search yielded 1124 papers, and 8 studies met eligibility criteria. Eligibility criteria included reporting on sexual function using the Female Sexual Function Index (FSFI), MIH for benign and nonurogynecological conditions, and a study population of premenopausal women. MIH routes included laparoscopic and vaginal surgeries. The primary outcome of interest was a change in the total FSFI score and domains pre- and postsurgery.

Meta-analysis was performed for each outcome using Cochrane Review Manager 5. Mean differences and 95% confidence intervals (CI) were calculated using pre- and postsurgery FSFI scores. The mean difference between pre- and posthysterectomy FSFI scores showed a small statistically significant improvement in sexual function after surgery: -1.54 (CI -2.83, -0.25). There were small statistically significant improvements in sexual function in the domains of desire (-0.75, CI -1.34, -0.17), arousal (-0.85, CI -1.46, -0.25), orgasm (-0.46, CI -0.81, -0.12), and satisfaction (-0.69, CI -1.20, -0.18). There were no statistically significant changes in the domains of lubrication and pain. The level of evidence is low, with moderate heterogeneity and risk of bias.

After hysterectomy with ovarian preservation, premenopausal women report small, yet statistically significant, improvement in overall sexual function, which is not likely clinically significant.